Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sierra Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sierra Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sierra Oncology Acquires Momelotinib and Activin Receptor from Gilead Sciences 11
Venture Financing 13
ProNAi Therapeutics Raises USD1.3 Million in Venture Financing 13
ProNAi Therapeutics Raises US$59.5 Million In Series D Financing 14
ProNAi Therapeutics Raises US$12 Million In Series C Financing 16
ProNAi Therapeutics Raises US$11 Million In Venture Financing 17
ProNAi Therapeutics Raises US$4.3 Million In Venture Financing 18
ProNAi Therapeutics Raises USD0.3 Million in Venture Financing 19
Licensing Agreements 20
ProNAi Therapeutics Enters into Licensing Agreement with CRT Pioneer 20
ProNAi Therapeutics Enters into Licensing Agreement with Carna Biosciences 21
Marina Biotech Enters Into Licensing Agreement With ProNAi Therapeutics For DNAi Therapeutics 22
Equity Offering 23
Sierra Oncology Plans to Raise up to USD200 Million in Public Offering of Securities 23
Sierra Oncology Prices Public Offering of Shares for USD42.8 Million 24
Sierra Oncology Completes Public Offering of Shares for USD29.5 Million 26
ProNAi Therapeutics Raises USD158.4 Million in IPO 28
Sierra Oncology Inc – Key Competitors 30
Sierra Oncology Inc – Key Employees 31
Sierra Oncology Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 09, 2018: Sierra Oncology Reports Second Quarter Results 33
May 10, 2018: Sierra Oncology Reports First Quarter Results 35
Feb 27, 2018: Sierra Oncology Reports 2017 Year End Results 36
Nov 08, 2017: Sierra Oncology Reports Third Quarter Results 38
Aug 10, 2017: Sierra Oncology Reports Second Quarter 2017 Results 40
May 09, 2017: Sierra Oncology Reports First Quarter 2017 Results 42
Mar 02, 2017: Sierra Oncology Reports 2016 Year-End Results 43
Product News 45
02/27/2018: Sierra Oncology Provides Update on SRA141 45
02/06/2018: Sierra Oncology to host program update on SRA141 on February 27th in New York 46
Other Significant Developments 47
Jan 09, 2017: ProNAi Relaunched as Sierra Oncology to Advance DDR-Based Cancer Drugs 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sierra Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sierra Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Sierra Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sierra Oncology Acquires Momelotinib and Activin Receptor from Gilead Sciences 11
ProNAi Therapeutics Raises USD1.3 Million in Venture Financing 13
ProNAi Therapeutics Raises US$59.5 Million In Series D Financing 14
ProNAi Therapeutics Raises US$12 Million In Series C Financing 16
ProNAi Therapeutics Raises US$11 Million In Venture Financing 17
ProNAi Therapeutics Raises US$4.3 Million In Venture Financing 18
ProNAi Therapeutics Raises USD0.3 Million in Venture Financing 19
ProNAi Therapeutics Enters into Licensing Agreement with CRT Pioneer 20
ProNAi Therapeutics Enters into Licensing Agreement with Carna Biosciences 21
Marina Biotech Enters Into Licensing Agreement With ProNAi Therapeutics For DNAi Therapeutics 22
Sierra Oncology Plans to Raise up to USD200 Million in Public Offering of Securities 23
Sierra Oncology Prices Public Offering of Shares for USD42.8 Million 24
Sierra Oncology Completes Public Offering of Shares for USD29.5 Million 26
ProNAi Therapeutics Raises USD158.4 Million in IPO 28
Sierra Oncology Inc, Key Competitors 30
Sierra Oncology Inc, Key Employees 31
Sierra Oncology Inc, Subsidiaries 32
List of Figures
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sierra Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sierra Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9